Karmanos Cancer Institute Wins $1.3M Pentagon Grant to Remain in Prostate Cancer Clinical Trials Consortium

Karmanos Cancer Institute Wins $1.3M Pentagon Grant to Remain in Prostate Cancer Clinical Trials Consortium
Detroit's Barbara Ann Karmanos Cancer Institute has snared a four-year, $1.23 million grant renewal from the U.S. Department of Defense to keep its membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. Karmanos, a member of the consortium since 2008, was one of only seven sites funded this year, down from 11 sites in 2013. Leading the institute's involvement in the consortium will be Dr. Elisabeth Heath, who heads the genitourinary oncology multidisciplinary team at Karmanos. “African-American men face numerous socioeconomic, religious and health barriers to participating in clinical trial-based therapy," Heath said in a
Subscribe or to access all post and page content.